Job/Unit: O20913
/KAP1
Date: 10-09-12 12:01:02
Pages: 13
R. Narayan, C.-G. Daniliuc, E.-U. Würthwein
FULL PAPER
calcd. for C1 9 H1 7 ClN2 ONa 347.0927; found 347.0922.
C19H17ClN2O (324.81): calcd. C 70.26, H 5.28, N 8.62; found C
69.22, H 5.44, N 8.52.
(1E,3E)-4-(3-Fluorophenyl)-1-(indolin-1-ylimino)-1-phenylbut-3-en-
2-one (9f): Compound 9f was produced from 13 (0.372 g, 1 mmol)
and 3-fluorobenzaldehyde (0.14 g, 1.1 mmol) by the general pro-
cedure, being obtained (0.21 g, 0.58 mmol, 58%) as a yellow solid 521
(m.p. 142–143 °C) after recrystallization. 1H NMR (300 MHz,
CDCl3): δ = 2.94 (t, J = 8.2 Hz, 2 H, NCH2CH2), 3.24 (t, J =
8.2 Hz, 2 H, NCH2CH2), 6.94 (td, J = 7.3, 1.1 Hz, 1 H, CHar),
6.98–7.03 (m, 1 H, CHar), 7.06–7.09 (m, 1 H, CHar), 7.22–7.26 (m,
3 H, CHar), 7.30–7.36 (m, 7 H, CHar), 7.57 (d, J = 16.0 Hz, 1 H, 526
CHol), 8.10 (d, J = 16.0 Hz, 1 H, CHol) ppm. 13C NMR (75 MHz,
CDCl3): δ = 28.0 (NCH2CH2), 53.5 (NCH2CH2), 111.3 (CHar/ol),
(1E,4E)-4-(Indolin-1-ylimino)-1-(p-tolyl)pent-1-en-3-one (9d): Com-
pound 9d was prepared from 11 (0.404 g, 2 mmol) and 4-methyl-
benzaldehyde (0.24 g, 2 mmol) by the general procedure. The com-
pound (0.515 g, 0.17 mmol, 85%) was obtained as a yellow solid
(m.p. 93–95 °C) after filtration and recrystallization from meth-
anol. 1H NMR (300 MHz, CD2Cl2): δ = 2.19 (s, 3 H, CH3CN),
2.28 (s, 3 H, CH3Ph), 3.14 (t, J = 8.2 Hz, 2 H, NCH2CH2), 4.07
(t, J = 8.2 Hz, 2 H, NCH2CH2), 6.86–6.90 (m, 1 H, CHar), 7.07–
7.11 (m, 1 H, CHar), 7.13 (d, J = 8.1 Hz, 2 H, CHar), 7.16–7.18 (m,
2 H, CHar), 7.50 (d, J = 8.1 Hz, 2 H, CHar), 7.52 (d, J = 16.0 Hz,
1 H, CHol), 7.93 (d, J = 16.0 Hz, 1 H, CHol) ppm. 13C NMR
(75 MHz, CD2Cl2): δ = 13.4 (CH3CN), 21.6 (CH3Ph), 28.5
(NCH2CH2), 53.7 (NCH2CH2), 111.8 (CHar/ol), 120.9 (CHar/ol),
122.9 (CHar/ol), 125.3 (CHar/ol), 128.2 (CHar/ol), 128.5 (Cq), 128.6
(CHar/ol), 129.9 (CHar/ol), 133.4 (Cq), 140.7 (Cq), 140.9 (CHar/ol),
461
466
471
476
481
2
2
114.3 (d, J = 21.7 Hz, CHar), 116.5 (d, J = 21.7 Hz, CHar), 121.6
(CHar/ol), 123.4 (CHar/ol), 124.3 (d, 4J = 2.8 Hz, CHar), 125.2
(CHar/ol), 127.6 (CHar/ol), 128.2 (CHar/ol), 128.3 (CHar/ol), 128.6 531
3
(CHar/ol), 130.3 (d, J = 8.4 Hz, CHar), 130.8 (Cq), 130.4 (CHar/ol),
134.4 (Cq), 138.1 (d, 3J = 7.6 Hz, Cq), 139.5 (Cq), 139.5, 141.4 (Cq),
147.8 (Cq), 163.0 (d, 1J = 246.1 Hz, CFar), 187.2 (C=O) ppm. IR
(neat): ν = 3444 (w), 3376 (w), 3228 (w), 2356 (w), 2143 (w), 2133
˜
(w), 1638 (s), 1611 (s), 1554 (s), 1494 (m), 1333 (m), 1329 (s), 1269
(s), 1241 (m), 1172 (m), 1115 (m), 1102 (m), 1091 (s), 1065 (s), 1011
(m), 975 (s), 892 (s), 757 (m), 716 (m), 702 (m), 697 (m), 668
(m) cm–1. HRMS (ESI): calcd. for C24H19FN2ONa 393.1379;
found 393.1374.
536
143.6 (C ), 149.7 (C ), 188.2 (C=O) ppm. IR (neat): ν = 2361 (w),
˜
q
q
2340 (w), 1665 (s), 1647 (s), 1605 (s), 1595 (s), 1558 (s), 1481 (m),
1329 (m), 1296 (s), 1261 (s), 1221 (w), 1206 (w), 1167 (m), 1115
(m), 1067 (s), 1028 (s), 1005 (m), 829 (m), 810 (m), 741 (s) cm–1.
HRMS (ESI): calcd. for C20H20N2ONa 327.1473; found 327.1468.
(1E,3E)-4-(4-Chlorophenyl)-1-(indolin-1-ylimino)-1-phenylbut-3-en- 541
2-one (9g): Compound 9g was produced from 13 (0.372 g, 1 mmol)
and 4-chlorobenzaldehyde (0.155 g, 1.1 mmol) by the general pro-
cedure, being obtained (0.227 g, 0.59 mmol, 59%) as a yellow solid
(m.p. 137–139 °C) after recrystallization. 1H NMR (300 MHz,
CDCl3): δ = 2.94 (t, J = 8.2 Hz, 2 H, NCH2CH2), 3.23 (t, J = 546
8.2 Hz, 2 H, NCH2CH2), 6.93 (td, J = 7.3, 1.1 Hz, 1 H, CHar), 7.07
(d, J = 7.3 Hz, 1 H, CHar), 7.21–7.24 (m, 3 H, CHar), 7.29–7.32
(m, 6 H, CHar), 7.50 (d, J = 8.4 Hz, 2 H, CHar), 7.56 (d, J =
16.0 Hz, 1 H, CHol), 8.07 (d, J = 16.0 Hz, 1 H, CHol) ppm. 13C
NMR (75 MHz, CDCl3): δ = 28.0 (NCH2CH2), 53.5 (NCH2CH2), 551
111.2 (CHar/ol), 122.6 (CHar/ol), 123.4 (CHar/ol), 125.2 (CHar/ol),
127.6 (CHar/ol), 128.1 (CHar/ol), 128.3 (CHar/ol), 128.6 (CHar/ol),
129.1 (CHar/ol), 129.4 (CHar/ol), 130.4 (Cq), 134.4 (Cq), 134.5 (Cq),
135.5 (Cq), 139.5 (CHar/ol), 141.5 (Cq), 147.9 (Cq), 187.2
C
20H20N2O (304.39): calcd. C 78.92, H 6.62, N 9.20; found C
78.56, H 6.56, N 9.24.
General Procedure for the Preparation of Compounds 9e–i: tBuOK
(1 equiv.) was placed in a dry Schlenk flask and dissolved in abs.
THF (10 mLmmol–1). Ketophosphonate 13 (1 equiv.) was then
added as a solution in THF (2 mLmmol–1). This reaction mixture
was stirred at room temp. for one hour, followed by the addition
of the appropriate aldehyde (1.1 equiv.) dissolved in THF. The pro-
gress of the reaction was monitored by TLC. After the completion
of the reaction, the solvent was evaporated in vacuo. The residue
was dissolved in CH2Cl2, washed with brine, dried with MgSO4,
and concentrated to afford the crude product. The product was
purified by recrystallization from CH2Cl2.
486
491
The products were found to be extremely susceptible to decomposi-
tion in the presence of acidic impurities, so column chromatog-
raphy could not be used for purification. However, the compounds
could be purified by recrystallization from CH2Cl2 and were found
(C=O) ppm. IR (neat): ν = 3455 (w), 3387 (w), 2361 (w), 2280 (w),
556
˜
2154 (w), 1640 (s), 1610 (s), 1537 (s), 1521 (m), 1427 (m), 1352 (s),
1287 (s), 1242 (m), 1173 (m), 1116 (m), 1105 (m), 1087 (s), 1065
(s), 1031 (m), 957 (s), 834 (s), 750 (m), 734 (m), 656 (m), 633
(m) cm–1. HRMS (ESI): calcd. for C24H19ClN2ONa 409.1084;
found 409.1078.
496
1
to be of high purity by H NMR spectroscopy.
561
(1E,3E)-1-(Indolin-1-ylimino)-1,4-diphenylbut-3-en-2-one (9e):
Compound 9e was obtained from 13 (0.372 g, 1 mmol) and benzal-
dehyde (0.11 mL, 1.1 mmol) by the general procedure. Subsequent
recrystallization gave 9e (0.25 g, 0.72 mmol, 72%) as a yellow solid
(1E,3E)-1-(Indolin-1-ylimino)-1-phenyl-4-(p-tolyl)but-3-en-2-one
(9h): Compound 9h was produced from 13 (0.372 g, 1.0 mmol) and
4-methylbenzaldehyde (0.132 g, 1.1 mmol) by the general pro-
cedure, being obtained (0.2 g, 0.55 mmol, 55%) as a yellow solid
501
506
511
516
1
(m.p. 127–128 °C). H NMR (300 MHz, CDCl3): δ = 2.93 (t, J =
8.2 Hz, 2 H, NCH2CH2), 3.22 (t, J = 8.2 Hz, 2 H, NCH2CH2), (m.p. 122–123 °C) after recrystallization. 1H NMR (300 MHz,
6.92 (td, J = 7.4, 0.7 Hz, 1 H, CHar), 7.06 (d, J = 7.3 Hz, 1 H, CD2Cl2): δ = 2.30 (s, 3 H, CH3Ph), 2.90 (t, J = 8.2 Hz, 2 H,
CHar), 7.22–7.26 (m, 3 H, CHar), 7.30–7.36 (m, 7 H, CHar), 7.59 NCH2CH2), 3.19 (t, J = 8.2 Hz, 2 H, NCH2CH2), 6.90 (td, J = 7.4,
1.1 Hz, 1 H, CHar), 7.07–7.08 (m, 1 H, CHar), 7.16 (d, J = 8.0 Hz,
1 H, CHar), 7.21–7.23 (m, 3 H, CHar), 7.30–7.35 (m, 4 H, CHar),
= 26.9 (NCH2CH2), 52.4 (NCH2CH2), 110.2 (CHar/ol), 121.0 7.50 (d, J = 8.0 Hz, 2 H, CHar), 7.54 (d, J = 16.0 Hz, 1 H, CHol),
(CHar/ol), 122.1 (CHar/ol), 124.1 (CHar/ol), 126.5 (CHar/ol), 127.1 8.09 (d, J = 16.0 Hz, 1 H, CHol) ppm. 13C NMR (75 MHz,
(CHar/ol), 127.21 (CHar/ol), 127.22 (CHar/ol), 127.5 (CHar/ol), 127.8 CD2Cl2): δ = 21.6 (CH3Ph), 28.4 (NCH2CH2), 53.8 (NCH2CH2),
566
571
576
(d, J = 7.3 Hz, 2 H, CHar), 7.63 (d, J = 16.0 Hz, 1 H, CHol), 8.12
(d, J = 16.0 Hz, 1 H, CHol) ppm. 13C NMR (75 MHz, CDCl3): δ
(CHar/ol), 128.7 (Cq), 129.3 (CHar/ol), 133.5 (Cq), 134.8 (Cq), 139.9
(CHar/ol), 140.5 (C ), 146.9 (C ), 187.4 (C=O) ppm. IR (neat): ν =
3458 (m), 3421 (m), 2359 (w), 2180 (w), 2154 (w), 1653 (s), 1607
111.5 (CHar/ol), 121.6 (CHar/ol), 123.4 (CHar/ol), 125.5 (CHar/ol),
127.8 (CHar/ol), 128.3 (CHar/ol), 128.6 (CHar/ol), 128.8 (CHar/ol),
128.9 (Cq), 129.9 (CHar/ol), 130.9 (CHar/ol), 133.4 (Cq), 135.4 (Cq),
˜
q
q
(s), 1547 (s), 1481 (m), 1325 (m), 1302 (s), 1269 (s), 1240 (m), 1163 140.7 (Cq), 140.8 (CHar/ol), 141.7 (Cq), 148.4 (Cq), 187.7
(m), 1126 (m), 1115 (m), 1103 (s), 1065 (s), 1011 (m), 957 (s), 829 (C=O) ppm. IR (neat): ν = 3443 (w), 3381 (w), 2367 (w), 21940
˜
(s), 750 (m), 716 (m), 696 (m) cm–1. HRMS (ESI): calcd. for
C24H20N2OH: 353.1654; found 353.1648.
(w), 2156 (w), 1647 (s), 1607 (s), 1556 (s), 1471 (m), 1355 (s), 1299
(s), 1269 (s), 1243 (m), 1223 (m), 1213 (s), 1136 (m), 1120 (m), 1103
8
www.eurjoc.org
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 0000, 0–0